Search
- 4 days ago
Myeloid Therapeutics to Participate at Investor Conferences in June 2022
Myeloid Therapeutics to Participate at Investor Conferences in June 2022
22 views
- May 19
Myeloid Therapeutics Enters Into Agreement with Acuitas Therapeutics for Lipid Nanoparticle System..
Myeloid Therapeutics Enters Into Agreement with Acuitas Therapeutics for Lipid Nanoparticle (LNP) System, Enabling the First-Ever...
145 views
- May 11
Myeloid Therapeutics Doses First Patient with MT-101 in the IMAGINE Phase 1/2 Clinical Study...
Myeloid Therapeutics Doses First Patient with MT-101 in the IMAGINE Phase 1/2 Clinical Study
325 views
- Apr 27
Myeloid Therapeutics to Participate in Morgan Stanley Private Company Biotech Corporate Access Day
Myeloid Therapeutics to Participate in Morgan Stanley Private Company Biotech Corporate Access Day
56 views